标题
Immunology of Lynch Syndrome
作者
关键词
-
出版物
Current Oncology Reports
Volume 23, Issue 8, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-06-14
DOI
10.1007/s11912-021-01085-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Molecular Pathology of Lynch Syndrome
- (2020) G Cerretelli et al. JOURNAL OF PATHOLOGY
- Phase I Trial of a Modified Vaccinia Ankara Priming Vaccine Followed by a Fowlpox Virus Boosting Vaccine Modified to Express Brachyury and Costimulatory Molecules in Advanced Solid Tumors
- (2020) Julie M. Collins et al. ONCOLOGIST
- Dual targeting of TGF-β and PD-L1 via a bifunctional anti-PD-L1/TGF-βRII agent: status of preclinical and clinical advances
- (2020) Hanne Lind et al. Journal for ImmunoTherapy of Cancer
- Outcomes of Lynch syndrome (LS) patients treated with immune checkpoint inhibitors (ICI).
- (2020) Shahla Bari et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab versus chemotherapy for microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer: The phase 3 KEYNOTE-177 Study.
- (2020) Thierry Andre et al. JOURNAL OF CLINICAL ONCOLOGY
- Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity
- (2020) Lucas A Horn et al. Journal for ImmunoTherapy of Cancer
- The Use of a Humanized NSG-β2m−/− Model for Investigation of Immune and Anti-tumor Effects Mediated by the Bifunctional Immunotherapeutic Bintrafusp Alfa
- (2020) Y. Maurice II Morillon et al. Frontiers in Oncology
- A Frameshift Peptide Neoantigen-Based Vaccine for Mismatch Repair-Deficient Cancers: A Phase I/IIa Clinical Trial
- (2020) Matthias Kloor et al. CLINICAL CANCER RESEARCH
- Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa
- (2020) Laura Reyes-Uribe et al. GUT
- Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial
- (2020) John Burn et al. LANCET
- A Phase 1 Dose Escalation Trial of BN-CV301, a Recombinant Poxviral Vaccine Targeting MUC1 and CEA with Costimulatory Molecules
- (2019) Margaret E Gatti-Mays et al. CLINICAL CANCER RESEARCH
- Temporal changes within the (bladder) tumor microenvironment that accompany the therapeutic effects of the immunocytokine NHS-IL12
- (2019) Y. Maurice Morillon et al. Journal for ImmunoTherapy of Cancer
- Immune Activation in Mismatch Repair Deficient Carcinogenesis: More Than Just Mutational Rate
- (2019) Jason A. Willis et al. CLINICAL CANCER RESEARCH
- Prospects for combining immune checkpoint blockade with PARP inhibition
- (2019) Anping Li et al. Journal of Hematology & Oncology
- Dual Checkpoint Inhibition with Ipilimumab plus Nivolumab After Progression on Sequential PD‐1/PDL‐1 Inhibitors Pembrolizumab and Atezolizumab in a Patient with Lynch Syndrome, Metastatic Colon, and Localized Urothelial Cancer
- (2019) Arthur Winer et al. ONCOLOGIST
- Cooperative Immune-Mediated Mechanisms of the HDAC Inhibitor Entinostat, an IL15 Superagonist, and a Cancer Vaccine Effectively Synergize as a Novel Cancer Therapy
- (2019) Kristin C. Hicks et al. CLINICAL CANCER RESEARCH
- Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability–High/Mismatch Repair–Deficient Metastatic Colorectal Cancer: KEYNOTE-164
- (2019) Dung T. Le et al. JOURNAL OF CLINICAL ONCOLOGY
- A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)‐Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer
- (2019) Margaret E. Gatti‐Mays et al. ONCOLOGIST
- Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
- (2018) Michael J. Overman et al. JOURNAL OF CLINICAL ONCOLOGY
- ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
- (2018) John M Wrangle et al. LANCET ONCOLOGY
- Anti-PD-L1/TGFβR2 (M7824) fusion protein induces immunogenic modulation of human urothelial carcinoma cell lines, rendering them more susceptible to immune-mediated recognition and lysis
- (2018) Italia Grenga et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine
- (2018) Karin M. Knudson et al. OncoImmunology
- Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell types
- (2018) Kristin C. Hicks et al. OncoImmunology
- Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome
- (2018) Kyle Chang et al. JAMA Oncology
- Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease
- (2018) Michael M. Boyiadzis et al. Journal for ImmunoTherapy of Cancer
- Single-Agent Immunotherapy for Two Types of Cancer in One Patient
- (2018) Benjamin Musher et al. ANNALS OF INTERNAL MEDICINE
- Abstract LB-305: Randomized, double-blind, placebo-controlled immunoprevention trial with MUC1 vaccine in patients with newly diagnosed advanced adenomas
- (2018) Robert E. Schoen et al. CANCER RESEARCH
- Lynch Syndrome–Associated Colorectal Cancer
- (2018) Frank A. Sinicrope NEW ENGLAND JOURNAL OF MEDICINE
- Immunoprofiles of colorectal cancer from Lynch syndrome
- (2018) Joanna Walkowska et al. OncoImmunology
- Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16–Related Cancer
- (2018) Erminia Massarelli et al. JAMA Oncology
- Vaccines as an Integral Component of Cancer Immunotherapy
- (2018) Jeffrey Schlom et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
- (2017) Michael J Overman et al. LANCET ONCOLOGY
- First FDA Approval Agnostic of Cancer Site — When a Biomarker Defines the Indication
- (2017) Steven Lemery et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-L1 expression in HNPCC-associated colorectal cancer
- (2017) Naila Shiraliyeva et al. PATHOLOGY RESEARCH AND PRACTICE
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Mutation of TGFβ-RII eliminates NSAID cancer chemoprevention
- (2017) Juana Martín-López et al. Oncotarget
- Human Tumor Antigens Yesterday, Today, and Tomorrow
- (2017) Olivera J. Finn Cancer Immunology Research
- A Blueprint to Advance Colorectal Cancer Immunotherapies
- (2017) Dung T. Le et al. Cancer Immunology Research
- A novel bifunctional anti-PD-L1/TGF-β Trap fusion protein (M7824) efficiently reverts mesenchymalization of human lung cancer cells
- (2017) Justin M. David et al. OncoImmunology
- High numbers of PDCD1 (PD-1)-positive T cells and B2M mutations in microsatellite-unstable colorectal cancer
- (2017) Jonas Janikovits et al. OncoImmunology
- Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers
- (2016) Jung Ho Kim et al. BRITISH JOURNAL OF CANCER
- Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer
- (2016) Aung Ko Win et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Cancer immunoprevention
- (2016) Olivera J Finn et al. CURRENT OPINION IN IMMUNOLOGY
- Update on Lynch syndrome genomics
- (2016) Päivi Peltomäki Familial Cancer
- MUC1 stimulates EGFR expression and function in endometrial cancer
- (2016) Brian J. Engel et al. Oncotarget
- Brachyury identifies a class of enteroendocrine cells in normal human intestinal crypts and colorectal cancer
- (2016) Jana Jezkova et al. Oncotarget
- IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas
- (2016) Peter S. Kim et al. Oncotarget
- Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer
- (2015) Joseph P. Balint et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Concomitant mutation and epimutation of the MLH1 gene in a Lynch syndrome family
- (2015) Giulia Cini et al. CARCINOGENESIS
- American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Lynch Syndrome
- (2015) Joel H. Rubenstein et al. GASTROENTEROLOGY
- American Gastroenterological Association Technical Review on the Diagnosis and Management of Lynch Syndrome
- (2015) Uri Ladabaum et al. GASTROENTEROLOGY
- Obesity, Aspirin, and Risk of Colorectal Cancer in Carriers of Hereditary Colorectal Cancer: A Prospective Investigation in the CAPP2 Study
- (2015) Mohammad Movahedi et al. JOURNAL OF CLINICAL ONCOLOGY
- Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome
- (2015) Driss Ait Ouakrim et al. JNCI-Journal of the National Cancer Institute
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer
- (2015) John M Carethers WORLD JOURNAL OF GASTROENTEROLOGY
- Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy
- (2015) Mihaela Angelova et al. GENOME BIOLOGY
- Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome
- (2015) Driss Ait Ouakrim et al. JNCI-Journal of the National Cancer Institute
- Low density of FOXP3-positive T cells in normal colonic mucosa is related to the presence of beta2-microglobulin mutations in Lynch syndrome-associated colorectal cancer
- (2015) Fabian Echterdiek et al. OncoImmunology
- The colorectal cancer immune paradox revisited
- (2015) Mihaela Angelova et al. OncoImmunology
- Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial
- (2014) D. Klingbiel et al. ANNALS OF ONCOLOGY
- Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies
- (2014) S. Venderbosch et al. CLINICAL CANCER RESEARCH
- Colonoscopy screening compliance and outcomes in patients with Lynch syndrome
- (2014) K. Newton et al. Colorectal Disease
- New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape
- (2014) Deepak Mittal et al. CURRENT OPINION IN IMMUNOLOGY
- Defining HNPCC and Lynch syndrome: what's in a name?: Table 1
- (2014) S E Kravochuck et al. GUT
- TGF- : Duality of Function Between Tumor Prevention and Carcinogenesis
- (2014) D. R. Principe et al. JNCI-Journal of the National Cancer Institute
- Detection of coding microsatellite frameshift mutations in DNA mismatch repair-deficient mouse intestinal tumors
- (2014) Stefan M. Woerner et al. MOLECULAR CARCINOGENESIS
- Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients
- (2013) Michael A. Morse et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Towards a vaccine to prevent cancer in Lynch syndrome patients
- (2013) Magnus von Knebel Doeberitz et al. Familial Cancer
- T cell responses against microsatellite instability-induced frameshift peptides and influence of regulatory T cells in colorectal cancer
- (2012) Kathrin Bauer et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes
- (2012) Monica Bernal et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study
- (2012) T. Kimura et al. Cancer Prevention Research
- Molecular Pathways: Microsatellite Instability in Colorectal Cancer: Prognostic, Predictive, and Therapeutic Implications
- (2012) F. A. Sinicrope et al. CLINICAL CANCER RESEARCH
- Infiltration of Lynch Colorectal Cancers by Activated Immune Cells Associates with Early Staging of the Primary Tumor and Absence of Lymph Node Metastases
- (2012) Noel F.C.C. de Miranda et al. CLINICAL CANCER RESEARCH
- Prognostic impact of β-2-microglobulin expression in colorectal cancers stratified by mismatch repair status
- (2012) Viktor Hendrik Koelzer et al. JOURNAL OF CLINICAL PATHOLOGY
- Risks of Primary Extracolonic Cancers Following Colorectal Cancer in Lynch Syndrome
- (2012) A. K. Win et al. JNCI-Journal of the National Cancer Institute
- Cancer classification using the Immunoscore: a worldwide task force
- (2012) Jérôme Galon et al. Journal of Translational Medicine
- Aspirin and Low-Dose Nitric Oxide-Donating Aspirin Increase Life Span in a Lynch Syndrome Mouse Model
- (2011) M. A. Mcilhatton et al. Cancer Prevention Research
- Brachyury expression predicts poor prognosis at early stages of colorectal cancer
- (2011) Nerbil Kilic et al. EUROPEAN JOURNAL OF CANCER
- Strategies to target molecules that control the acquisition of a mesenchymal-like phenotype by carcinoma cells
- (2011) Claudia Palena et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- BRACHYURY confers cancer stem cell characteristics on colorectal cancer cells
- (2011) Debalina Sarkar et al. INTERNATIONAL JOURNAL OF CANCER
- Frequency of Deletions of EPCAM (TACSTD1) in MSH2-Associated Lynch Syndrome Cases
- (2011) Kandelaria Rumilla et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
- (2011) John Burn et al. LANCET
- Current Hypotheses on How Microsatellite Instability Leads to Enhanced Survival of Lynch Syndrome Patients
- (2010) Kristen M. Drescher et al. Clinical & Developmental Immunology
- Immune evasion of microsatellite unstable colorectal cancers
- (2010) Matthias Kloor et al. INTERNATIONAL JOURNAL OF CANCER
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
- (2010) Daniel J. Sargent et al. JOURNAL OF CLINICAL ONCOLOGY
- Microsatellite instability in colorectal cancer—the stable evidence
- (2010) Eduardo Vilar et al. Nature Reviews Clinical Oncology
- Deficient mismatch repair system in patients with sporadic advanced colorectal cancer
- (2009) M Koopman et al. BRITISH JOURNAL OF CANCER
- Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis
- (2009) Gaëtan Des Guetz et al. EUROPEAN JOURNAL OF CANCER
- Serum antibodies against frameshift peptides in microsatellite unstable colorectal cancer patients with Lynch syndrome
- (2009) Miriam Reuschenbach et al. Familial Cancer
- An Msh2 Conditional Knockout Mouse for Studying Intestinal Cancer and Testing Anticancer Agents
- (2009) Melanie H. Kucherlapati et al. GASTROENTEROLOGY
- Germline hypermethylation ofMLH1andEPCAMdeletions are a frequent cause of Lynch syndrome
- (2009) Renée C. Niessen et al. GENES CHROMOSOMES & CANCER
- Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803
- (2009) Monica M. Bertagnolli et al. JOURNAL OF CLINICAL ONCOLOGY
- Fas Ligand Expression in Lynch Syndrome-Associated Colorectal Tumours
- (2009) Jan J. Koornstra et al. PATHOLOGY & ONCOLOGY RESEARCH
- Mismatch repair genes in Lynch syndrome: a review
- (2009) Felipe Cavalcanti Carneiro da Silva et al. Sao Paulo Medical Journal
- Immune Response Against Frameshift-Induced Neopeptides in HNPCC Patients and Healthy HNPCC Mutation Carriers
- (2008) Yvette Schwitalle et al. GASTROENTEROLOGY
- Immunology and the Lynch Syndrome
- (2008) Henry T. Lynch et al. GASTROENTEROLOGY
- Feasibility of Screening for Lynch Syndrome Among Patients With Colorectal Cancer
- (2008) Heather Hampel et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Aspirin or Resistant Starch on Colorectal Neoplasia in the Lynch Syndrome
- (2008) John Burn et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now